Case pg194, fig1,2A. Soma notes In case 1, inj site involves rostral & most lateral part of LEA, close to rhinal sulcus (Fig1). Majority of immunoreactive neurons are found in layers II & III & a small number are labeled in layer IV. --no figs of inj sites-. Terminal notes In hippocampus, terminal labeling is restricted to CA1 & subiculum & is predominantly present in the inner 1/2 of the molecular layer. --Fig2A: mod/dense--.

Case pg194, fig1. Soma notes Inj site centred in layers II & III of LEA, slightly caudal to that of case2 (fig1) --no figs of inj sites-. Terminal notes Terminal labeling is prominent in the inner half of molecular layers of CA1 & adjacent part of subiculum..

Case pg194-5, fig1,2B. Soma notes In a 4th rat, inj placed approx 1mm caudal to case1, in similar medlat posn. Immunoreactive neurons are found in layers II & III of LEA. --no figs of inj sites-. Terminal notes A labeled terminal field is further present in molecular layer of CA1, predominantnly in its inner 1/2, but labeling weaker than that in FD --Fig2B: moderate--.

Case pg195, fig1. Soma notes More caudally placed injections in LEA & MEA (cases5-8) ?--no figs of inj sites-. Terminal notes ?all result in labeling in FD, CA1 & subiculum. With exception of case 6 in which density of labeling in FD = that in CA1, the labeling in FD is more dense than in other hippocampal subfields.